Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 337

1.

Risk of neurological disorders in patients with European Lyme neuroborreliosis. A nationwide population-based cohort study.

Haahr R, Tetens MM, Dessau RB, Krogfelt KA, Bodilsen J, Andersen NS, Møller JK, Roed C, Christiansen CB, Ellermann-Eriksen S, Bangsborg JM, Hansen K, Benfield TL, Østergaard Andersen C, Obel N, Lebech AM, Omland LH.

Clin Infect Dis. 2019 Oct 9. pii: ciz997. doi: 10.1093/cid/ciz997. [Epub ahead of print]

PMID:
31598647
2.

Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE.

Thorsteinsson K, Ladelund S, Storgaard M, Katzenstein TL, Johansen IS, Pedersen G, Rönsholt FF, Nielsen LN, Nilas L, Franzmann M, Obel N, Lebech AM, Bonde J.

BMC Infect Dis. 2019 Aug 22;19(1):740. doi: 10.1186/s12879-019-4377-5.

3.

Mortality and Risk of Cancer After Prophylactic Bilateral Oophorectomy in Women With a Family History of Cancer.

Abildgaard J, Ahlström MG, Daugaard G, Nielsen DL, Pedersen AT, Lindegaard B, Obel N.

JNCI Cancer Spectr. 2018 Aug 11;2(3):pky034. doi: 10.1093/jncics/pky034. eCollection 2018 Jul.

4.

Cervical cancer risk in women living with HIV across four continents: A multicohort study.

Rohner E, Bütikofer L, Schmidlin K, Sengayi M, Maskew M, Giddy J, Taghavi K, Moore RD, Goedert JJ, Gill MJ, Silverberg MJ, D'Souza G, Patel P, Castilho JL, Ross J, Sohn A, Bani-Sadr F, Taylor N, Paparizos V, Bonnet F, Verbon A, Vehreschild JJ, Post FA, Sabin C, Mocroft A, Dronda F, Obel N, Grabar S, Spagnuolo V, Quiros-Roldan E, Mussini C, Miro JM, Meyer L, Hasse B, Konopnicki D, Roca B, Barger D, Clifford GM, Franceschi S, Egger M, Bohlius J.

Int J Cancer. 2019 Jun 19. doi: 10.1002/ijc.32260. [Epub ahead of print]

PMID:
31215037
5.

Primary health care: an opportunity for early identification of people living with undiagnosed HIV infection.

Martin-Iguacel R, Pedersen C, Llibre JM, Søndergaard J, Jensen J, Omland LH, Johansen IS, Obel N, Rasmussen LD.

HIV Med. 2019 Jul;20(6):404-417. doi: 10.1111/hiv.12735. Epub 2019 Apr 24.

PMID:
31016849
6.

Is HIV a provoking factor for venous thrombotic events?

Rasmussen LD, Obel N.

Lancet HIV. 2019 Mar;6(3):e144-e146. doi: 10.1016/S2352-3018(18)30363-1. Epub 2019 Feb 15. No abstract available.

PMID:
30777725
7.

How do we preserve health among adults living with HIV?

Rasmussen LD, Obel N.

Lancet HIV. 2019 Feb;6(2):e69-e70. doi: 10.1016/S2352-3018(18)30336-9. Epub 2019 Jan 22. No abstract available.

PMID:
30683626
8.

Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy.

Gras L, May M, Ryder LP, Trickey A, Helleberg M, Obel N, Thiebaut R, Guest J, Gill J, Crane H, Dias Lima V, dʼArminio Monforte A, Sterling TR, Miro J, Moreno S, Stephan C, Smith C, Tate J, Shepherd L, Saag M, Rieger A, Gillor D, Cavassini M, Montero M, Ingle SM, Reiss P, Costagliola D, Wit FWNM, Sterne J, de Wolf F, Geskus R; Antiretroviral Therapy Cohort Collaboration (ART-CC).

J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):292-300. doi: 10.1097/QAI.0000000000001913.

9.

A modeling study of the Danish HIV epidemic in men who have sex with men: travel, pre-exposure prophylaxis and elimination.

Palk L, Gerstoft J, Obel N, Blower S.

Sci Rep. 2018 Oct 30;8(1):16003. doi: 10.1038/s41598-018-33570-0.

10.

Association between smoking status assessed with plasma-cotinine and inflammatory and endothelial biomarkers in HIV-positive and HIV-negative individuals.

Ahlström MG, Knudsen A, Ullum H, Gerstoft J, Kjaer A, Lebech AM, Hasbak P, Obel N.

HIV Med. 2018 Nov;19(10):679-687. doi: 10.1111/hiv.12647. Epub 2018 Jul 9.

PMID:
29984882
11.

Long term survival, health, social functioning, and education in patients with European Lyme neuroborreliosis: nationwide population based cohort study.

Obel N, Dessau RB, Krogfelt KA, Bodilsen J, Andersen NS, Møller JK, Roed C, Omland LH, Christiansen CB, Ellermann-Eriksen S, Bangsborg JM, Hansen K, Benfield TL, Rothman KJ, Sørensen HT, Andersen CØ, Lebech AM.

BMJ. 2018 May 30;361:k1998. doi: 10.1136/bmj.k1998.

12.

Long-term risk and outcome of infection-related hospitalization in granulomatosis with polyangiitis: a nationwide population-based cohort study.

Faurschou M, Obel N, Baslund B.

Scand J Rheumatol. 2018 Nov;47(6):475-480. doi: 10.1080/03009742.2018.1461924. Epub 2018 May 9.

PMID:
29741122
13.

Non-AIDS Comorbid Conditions in Persons Living With Human Immunodeficiency Virus (HIV) Compared With Uninfected Individuals 10 Years Before HIV Diagnosis.

Ronit A, Gerstoft J, Nielsen L, Mohey R, Wiese L, Kvinesdal B, Obel N, Ahlströhm MG.

Clin Infect Dis. 2018 Sep 28;67(8):1291-1293. doi: 10.1093/cid/ciy325.

PMID:
29672667
14.

Multiple Homozygous Variants in the STING-Encoding TMEM173 Gene in HIV Long-Term Nonprogressors.

Nissen SK, Pedersen JG, Helleberg M, Kjær K, Thavachelvam K, Obel N, Tolstrup M, Jakobsen MR, Mogensen TH.

J Immunol. 2018 May 15;200(10):3372-3382. doi: 10.4049/jimmunol.1701284. Epub 2018 Apr 9.

15.

Risk of skin cancer in patients with HIV: A Danish nationwide cohort study.

Omland SH, Ahlström MG, Gerstoft J, Pedersen G, Mohey R, Pedersen C, Kronborg G, Larsen CS, Kvinesdal B, Gniadecki R, Obel N, Omland LH.

J Am Acad Dermatol. 2018 Oct;79(4):689-695. doi: 10.1016/j.jaad.2018.03.024. Epub 2018 Mar 26.

PMID:
29588249
16.

Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation.

Pettit AC, Giganti MJ, Ingle SM, May MT, Shepherd BE, Gill MJ, Fätkenheuer G, Abgrall S, Saag MS, Del Amo J, Justice AC, Miro JM, Cavasinni M, Dabis F, Monforte AD, Reiss P, Guest J, Moore D, Shepherd L, Obel N, Crane HM, Smith C, Teira R, Zangerle R, Sterne JA, Sterling TR; Antiretroviral Therapy Cohort Collaboration (ART-CC) investigators.

J Int AIDS Soc. 2018 Jan;21(1). doi: 10.1002/jia2.25031.

17.

CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study.

Wittkop L, Arsandaux J, Trevino A, Schim van der Loeff M, Anderson J, van Sighem A, Böni J, Brun-Vezinet F, Soriano V, Boufassa F, Brockmeyer N, Calmy A, Dabis F, Jarrin I, Dorrucci M, Duque V, Fätkenheuer G, Zangerle R, Ferrer E, Porter K, Judd A, Sipsas NV, Lambotte O, Shepherd L, Leport C, Morrison C, Mussini C, Obel N, Ruelle J, Schwarze-Zander C, Sonnerborg A, Teira R, Torti C, Valadas E, Colin C, Friis-Møller N, Costagliola D, Thiebaut R, Chene G, Matheron S; COHERE in EuroCoord and ACHIeV2e Study Group.

J Antimicrob Chemother. 2017 Oct 1;72(10):2869-2878. doi: 10.1093/jac/dkx210.

18.

Incidence, clinical presentation, and outcome of HIV-1-associated cryptococcal meningitis during the highly active antiretroviral therapy era: a nationwide cohort study.

Touma M, Rasmussen LD, Martin-Iguacel R, Engsig FN, Stærke NB, Stærkind M, Obel N, Ahlström MG.

Clin Epidemiol. 2017 Jul 21;9:385-392. doi: 10.2147/CLEP.S135309. eCollection 2017.

19.

Incidence, presentation and outcome of toxoplasmosis in HIV infected in the combination antiretroviral therapy era.

Martin-Iguacel R, Ahlström MG, Touma M, Engsig FN, Stærke NB, Stærkind M, Obel N, Rasmussen LD.

J Infect. 2017 Sep;75(3):263-273. doi: 10.1016/j.jinf.2017.05.018. Epub 2017 Jun 1.

PMID:
28579301
20.

Agreement between Estimated and Measured Renal Function in an Everyday Clinical Outpatient Setting of Human Immunodeficiency Virus-Infected Individuals.

Ahlström MG, Kjær A, Gerstoft J, Obel N.

Nephron. 2017;136(4):318-327. doi: 10.1159/000469668. Epub 2017 May 5.

PMID:
28472812
21.

Complete manuscript Title: Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults.

Mathiesen IH, Salem M, Gerstoft J, Gaardbo JC, Obel N, Pedersen C, Ullum H, Nielsen SD, Hansen AE.

BMC Infect Dis. 2017 Apr 11;17(1):262. doi: 10.1186/s12879-017-2368-y.

22.

Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers.

Chereau F, Madec Y, Sabin C, Obel N, Ruiz-Mateos E, Chrysos G, Fidler S, Lehmann C, Zangerle R, Wittkop L, Reiss P, Hamouda O, Estrada Perez V, Leal M, Mocroft A, Garcia De Olalla P, Ammassari A, D'Arminio Monforte A, Mussini C, Segura F, Castagna A, Cavassini M, Grabar S, Morlat P, De Wit S, Lambotte O, Meyer L; HIV Controllers Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCOORD.

PLoS One. 2017 Apr 5;12(4):e0173893. doi: 10.1371/journal.pone.0173893. eCollection 2017.

23.

The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges.

Gourlay A, Noori T, Pharris A, Axelsson M, Costagliola D, Cowan S, Croxford S, d'Arminio Monforte A, Del Amo J, Delpech V, Díaz A, Girardi E, Gunsenheimer-Bartmeyer B, Hernando V, Jose S, Leierer G, Nikolopoulos G, Obel N, Op de Coul E, Paraskeva D, Reiss P, Sabin C, Sasse A, Schmid D, Sonnerborg A, Spina A, Suligoi B, Supervie V, Touloumi G, Van Beckhoven D, van Sighem A, Vourli G, Zangerle R, Porter K; European HIV Continuum of Care Working Group.

Clin Infect Dis. 2017 Jun 15;64(12):1644-1656. doi: 10.1093/cid/cix212.

24.

Update of Survival for Persons With HIV Infection in Denmark.

Lohse N, Obel N.

Ann Intern Med. 2016 Nov 15;165(10):749-750. doi: 10.7326/L16-0091. No abstract available.

PMID:
27842400
25.

Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project.

Ngo-Giang-Huong N, Wittkop L, Judd A, Reiss P, Goetghebuer T, Duiculescu D, Noguera-Julian A, Marczynska M, Giacquinto C, Ene L, Ramos JT, Cellerai C, Klimkait T, Brichard B, Valerius N, Sabin C, Teira R, Obel N, Stephan C, de Wit S, Thorne C, Gibb D, Schwimmer C, Campbell MA, Pillay D, Lallemant M; EuroCoord-CHAIN-EPPICC joint project study group.

BMC Infect Dis. 2016 Nov 8;16(1):654.

26.

Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE.

Thorsteinsson K, Storgaard M, Katzenstein TL, Ladelund S, Rønsholt FF, Johansen IS, Pedersen G, Hashemi L, Nielsen LN, Nilas L, Obel N, Bonde J, Lebech AM.

BMC Cancer. 2016 Nov 8;16(1):866.

27.

HIV elimination and population viral load.

Okano JT, Gerstoft J, Obel N, Blower S.

Lancet HIV. 2016 Nov;3(11):e507-e509. doi: 10.1016/S2352-3018(16)30174-6. No abstract available.

28.

Risk of Diabetes Mellitus among Patients Diagnosed with Giant Cell Arteritis or Granulomatosis with Polyangiitis: Comparison with the General Population.

Faurschou M, Ahlström MG, Lindhardsen J, Obel N, Baslund B.

J Rheumatol. 2017 Jan;44(1):78-83. doi: 10.3899/jrheum.160797. Epub 2016 Oct 15.

PMID:
27744394
29.

Use of non-antiretroviral drugs among individuals with and without HIV-infection: a Danish nationwide study.

Rasmussen LD, Kronborg G, Larsen CS, Pedersen C, Gerstoft J, Obel N, Pottegård A.

Infect Dis (Lond). 2017 Jan;49(1):42-54. Epub 2016 Aug 11.

PMID:
27686116
30.

Five-year risk of HIV diagnosis subsequent to 147 hospital-based indicator diseases: a Danish nationwide population-based cohort study.

Omland LH, Legarth R, Ahlström MG, Sørensen HT, Obel N.

Clin Epidemiol. 2016 Sep 6;8:333-40. doi: 10.2147/CLEP.S101288. eCollection 2016. Erratum in: Clin Epidemiol. 2016 Nov 18;8:769.

31.

Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.

Judd A, Lodwick R, Noguera-Julian A, Gibb DM, Butler K, Costagliola D, Sabin C, van Sighem A, Ledergerber B, Torti C, Mocroft A, Podzamczer D, Dorrucci M, De Wit S, Obel N, Dabis F, Cozzi-Lepri A, García F, Brockmeyer NH, Warszawski J, Gonzalez-Tome MI, Mussini C, Touloumi G, Zangerle R, Ghosn J, Castagna A, Fätkenheuer G, Stephan C, Meyer L, Campbell MA, Chene G, Phillips A; Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.

HIV Med. 2017 Mar;18(3):171-180. doi: 10.1111/hiv.12411. Epub 2016 Sep 14.

32.

Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.

Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, d'Arminio Monforte A, Mary-Krause M, Roca B, Miro JM, Battegay M, Brockmeyer N, Berenguer J, Morlat P, Obel N, De Wit S, Fätkenheuer G, Zangerle R, Ghosn J, Pérez-Hoyos S, Campbell M, Prins M, Chêne G, Meyer L, Dorrucci M, Torti C, Thiébaut R; Standard Reference Distribution of CD4 Response to HAART Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.

HIV Med. 2017 Jan;18(1):33-44. doi: 10.1111/hiv.12389. Epub 2016 Sep 14.

33.

Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.

Pediatric AIDS-Defining Cancer Project Working Group for IeDEA Southern Africa, TApHOD, and COHERE in EuroCoord, Rohner E, Schmidlin K, Zwahlen M, Chakraborty R, Clifford G, Obel N, Grabar S, Verbon A, Noguera-Julian A, Collins IJ, Rojo P, Brockmeyer N, Campbell M, Chêne G, Prozesky H, Eley B, Stefan DC, Davidson A, Chimbetete C, Sawry S, Davies MA, Kariminia A, Vibol U, Sohn A, Egger M, Bohlius J.

Clin Infect Dis. 2016 Nov 1;63(9):1245-1253. Epub 2016 Aug 30.

34.

Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy.

Trickey A, May MT, Vehreschild J, Obel N, Gill MJ, Crane H, Boesecke C, Samji H, Grabar S, Cazanave C, Cavassini M, Shepherd L, d'Arminio Monforte A, Smit C, Saag M, Lampe F, Hernando V, Montero M, Zangerle R, Justice AC, Sterling T, Miro J, Ingle S, Sterne JA; Antiretroviral Therapy Cohort Collaboration (ART-CC).

PLoS One. 2016 Aug 15;11(8):e0160460. doi: 10.1371/journal.pone.0160460. eCollection 2016.

35.

Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma development.

Vase MØ, Ludvigsen M, Bendix K, Hamilton-Dutoit S, Mller MB, Pedersen C, Pedersen G, Obel N, Larsen CS, d'Amore F, Honoré B.

AIDS. 2016 Jul 31;30(12):1889-98. doi: 10.1097/QAD.0000000000001152.

PMID:
27177314
36.

Testing the hypothesis that treatment can eliminate HIV: a nationwide, population-based study of the Danish HIV epidemic in men who have sex with men.

Okano JT, Robbins D, Palk L, Gerstoft J, Obel N, Blower S.

Lancet Infect Dis. 2016 Jul;16(7):789-796. doi: 10.1016/S1473-3099(16)30022-6. Epub 2016 May 9.

37.

Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load.

Thørner LW, Erikstrup C, Harritshøj LH, Larsen MH, Kronborg G, Pedersen C, Larsen CS, Pedersen G, Gerstoft J, Obel N, Ullum H.

Infect Genet Evol. 2016 Jul;41:185-190. doi: 10.1016/j.meegid.2016.03.037. Epub 2016 Apr 12.

PMID:
27083073
38.

Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study.

May MT, Vehreschild JJ, Trickey A, Obel N, Reiss P, Bonnet F, Mary-Krause M, Samji H, Cavassini M, Gill MJ, Shepherd LC, Crane HM, d'Arminio Monforte A, Burkholder GA, Johnson MM, Sobrino-Vegas P, Domingo P, Zangerle R, Justice AC, Sterling TR, Miró JM, Sterne JAC; Antiretroviral Therapy Cohort Collaboration (ART-CC), Boulle A, Stephan C, Miro JM, Cavassini M, Chêne G, Costagliola D, Dabis F, Monforte AD, Del Amo J, Van Sighem A, Fätkenheuer G, Gill J, Guest J, Haerry DH, Hogg R, Justice A, Shepherd L, Obel N, Crane H, Smith C, Reiss P, Saag M, Sterling T, Teira R, Williams M, Zangerle R, Sterne J, May M, Ingle S, Trickey A.

Clin Infect Dis. 2016 Jun 15;62(12):1571-1577. doi: 10.1093/cid/ciw183. Epub 2016 Mar 29.

39.

Routine urine protein/creatinine ratio testing in an outpatient setting of Danish HIV-infected individuals.

Glindvad Ahlstrom M, Feldt-Rasmussen B, Gerstoft J, Obel N.

Infect Dis (Lond). 2016 Jul;48(7):560-2. doi: 10.3109/23744235.2016.1154600. Epub 2016 Mar 7. No abstract available.

PMID:
26950430
40.

Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study.

Podlekareva DN, Efsen AM, Schultze A, Post FA, Skrahina AM, Panteleev A, Furrer H, Miller RF, Losso MH, Toibaro J, Miro JM, Vassilenko A, Girardi E, Bruyand M, Obel N, Lundgren JD, Mocroft A, Kirk O; TB:HIV study group in EuroCoord.

Lancet HIV. 2016 Mar;3(3):e120-31. doi: 10.1016/S2352-3018(15)00252-0. Epub 2016 Feb 2.

PMID:
26939735
41.

Sexually transmitted infections and use of contraceptives in women living with HIV in Denmark - the SHADE cohort.

Thorsteinsson K, Ladelund S, Storgaard M, Rønsholt FF, Johansen IS, Pedersen G, Nielsen LN, Bonde J, Westh H, Obel N, Katzenstein TL, Lebech AM.

BMC Infect Dis. 2016 Feb 16;16:81. doi: 10.1186/s12879-016-1412-7.

42.

Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.

De Luca A, Flandre P, Dunn D, Zazzi M, Wensing A, Santoro MM, Günthard HF, Wittkop L, Kordossis T, Garcia F, Castagna A, Cozzi-Lepri A, Churchill D, De Wit S, Brockmeyer NH, Imaz A, Mussini C, Obel N, Perno CF, Roca B, Reiss P, Schülter E, Torti C, van Sighem A, Zangerle R, Descamps D; CHAIN and COHERE in EuroCoord.

J Antimicrob Chemother. 2016 May;71(5):1352-60. doi: 10.1093/jac/dkv465. Epub 2016 Jan 28.

43.

Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland--using spontaneous resolvers as the benchmark comparator.

Innes H, Hutchinson SJ, Obel N, Christensen PB, Aspinall EJ, Goldberg D, Krarup H, McDonald SA, McLeod A, Weir A, Omland LH.

Hepatology. 2016 May;63(5):1506-16. doi: 10.1002/hep.28458. Epub 2016 Mar 19.

PMID:
26773546
44.

Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America.

Efsen AM, Schultze A, Post FA, Panteleev A, Furrer H, Miller RF, Losso MH, Toibaro J, Skrahin A, Miro JM, Caylà JA, Girardi E, Bruyand M, Obel N, Podlekareva DN, Lundgren JD, Mocroft A, Kirk O; TB:HIV study group in EuroCoord.

PLoS One. 2015 Dec 30;10(12):e0145380. doi: 10.1371/journal.pone.0145380. eCollection 2015.

45.

Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013.

Late presenters working group in COHERE in EuroCoord, Mocroft A, Lundgren J, Antinori A, Monforte Ad, Brännström J, Bonnet F, Brockmeyer N, Casabona J, Castagna A, Costagliola D, De Wit S, Fätkenheuer G, Furrer H, Jadand C, Johnson A, Lazanas M, Leport C, Moreno S, Mussini C, Obel N, Post F, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Loano I, Torti C, Warszawski J, Wittkop L, Zangerle R, Chene G, Raben D, Kirk O.

Euro Surveill. 2015;20(47). doi: 10.2807/1560-7917.ES.2015.20.47.30070.

46.

Impact of pre-existing co-morbidities on mortality in granulomatosis with polyangiitis: a cohort study.

Faurschou M, Ahlström MG, Lindhardsen J, Baslund B, Obel N.

Rheumatology (Oxford). 2016 Apr;55(4):649-53. doi: 10.1093/rheumatology/kev390. Epub 2015 Nov 28.

PMID:
26615030
47.

Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.

McLaren PJ, Coulonges C, Bartha I, Lenz TL, Deutsch AJ, Bashirova A, Buchbinder S, Carrington MN, Cossarizza A, Dalmau J, De Luca A, Goedert JJ, Gurdasani D, Haas DW, Herbeck JT, Johnson EO, Kirk GD, Lambotte O, Luo M, Mallal S, van Manen D, Martinez-Picado J, Meyer L, Miro JM, Mullins JI, Obel N, Poli G, Sandhu MS, Schuitemaker H, Shea PR, Theodorou I, Walker BD, Weintrob AC, Winkler CA, Wolinsky SM, Raychaudhuri S, Goldstein DB, Telenti A, de Bakker PI, Zagury JF, Fellay J.

Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14658-63. doi: 10.1073/pnas.1514867112. Epub 2015 Nov 9.

48.

Incidence of benign prostate hypertrophy in Danish men with and without HIV infection.

Ahlström MG, Kronborg G, Larsen CS, Pedersen C, Pedersen G, Gerstoft J, Obel N.

AIDS. 2015 Nov;29(17):2315-22. doi: 10.1097/QAD.0000000000000804.

PMID:
26544703
49.

Long-term prognosis and causes of death after spondylodiscitis: A Danish nationwide cohort study.

Aagaard T, Roed C, Dahl B, Obel N.

Infect Dis (Lond). 2016;48(3):201-8. doi: 10.3109/23744235.2015.1103897. Epub 2015 Oct 20.

PMID:
26484577
50.

Associations between HIV and schizophrenia and their effect on HIV treatment outcomes: a nationwide population-based cohort study in Denmark.

Helleberg M, Pedersen MG, Pedersen CB, Mortensen PB, Obel N.

Lancet HIV. 2015 Aug;2(8):e344-50. doi: 10.1016/S2352-3018(15)00089-2. Epub 2015 Jul 2.

PMID:
26423377

Supplemental Content

Support Center